Labcorp Holdings (LH) Other Non-Current Liabilities (2009 - 2026)
Labcorp Holdings (LH) posted Other Non-Current Liabilities of $691.8 million for Q1 2026, up 6.79% sequentially from $647.8 million in Q4 2025, and up 38.94% YoY from $497.9 million in Q1 2025.
Labcorp Holdings (LH) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Labcorp Holdings has reported Other Non-Current Liabilities for 18 years, with the latest figure at $691.8 million in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 38.94% year-over-year to $691.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $691.8 million (up 38.94% YoY) and the FY2025 annual result came in at $647.8 million, up 25.2% from the prior year.
- Other Non-Current Liabilities climbed to $691.8 million in Q1 2026 per LH's latest filing, from $647.8 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $691.8 million in Q1 2026 and troughed at $401.1 million in Q4 2022.
- A 5-year average of $505.4 million and a median of $484.5 million in 2022 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2023 and 2026: Other Non-Current Liabilities declined 15.56% in 2023, then jumped 38.94% in 2026.
- Over 5 years, Other Non-Current Liabilities stood at $401.1 million in 2022, then climbed by 2.04% to $409.3 million in 2023, then grew by 26.41% to $517.4 million in 2024, then climbed by 25.2% to $647.8 million in 2025, then climbed by 6.79% to $691.8 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $691.8 million, $647.8 million, and $639.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 209.29 Bn | 205.35 Bn | 8.34 Bn |
| 2 | Danaher | 137.39 Bn | 133.06 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.84 Bn | 46.64 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.29 Bn | 37.48 Bn | 990.00 Mn |
| 5 | Natera | 39.28 Bn | 38.18 Bn | 696.04 Mn |
| 6 | Iqvia Holdings | 37.90 Bn | 35.95 Bn | 1.44 Bn |
| 7 | Illumina | 30.65 Bn | 29.49 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.92 Bn | 28.87 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 25.96 Bn | 25.64 Bn | 1.03 Bn |
| 10 | Labcorp Holdings | 25.71 Bn | 24.73 Bn | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 691.80 Mn |
| Dec 31, 2025 | 647.80 Mn |
| Sep 30, 2025 | 639.10 Mn |
| Jun 30, 2025 | 643.20 Mn |
| Mar 31, 2025 | 497.90 Mn |
| Dec 31, 2024 | 517.40 Mn |
| Sep 30, 2024 | 528.20 Mn |
| Jun 30, 2024 | 483.90 Mn |
| Mar 31, 2024 | 468.20 Mn |
| Dec 31, 2023 | 409.30 Mn |
| Sep 30, 2023 | 423.00 Mn |
| Jun 30, 2023 | 418.50 Mn |
| Mar 31, 2023 | 413.60 Mn |
| Dec 31, 2022 | 401.10 Mn |
| Sep 30, 2022 | 433.90 Mn |
| Jun 30, 2022 | 484.50 Mn |
| Mar 31, 2022 | 489.80 Mn |
| Dec 31, 2021 | 402.00 Mn |
| Sep 30, 2021 | 494.00 Mn |
| Jun 30, 2021 | 502.90 Mn |